Endpoints News 生物医药· Alex Hoffman·· 28 天前AI 评分30
Al Sandrock 将于明年第一季度卸任 Voyager Therapeutics CEO;Insmed 任命 Paul Hudson 加入董事会
Al Sandrock to step down as Voyager CEO; Insmed adds Paul Hudson to board
AI 导读
Voyager Therapeutics CEO Al Sandrock 将于明年第一季度卸任,但仍留任董事会成员。与此同时,Insmed 宣布任命 Paul Hudson 加入其董事会。
正文
→ Al Sandrock is calling it quits as CEO of Voyager Therapeutics in the first quarter next year, but he will stay on the board …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news